NEWMAN DIGNAN & SHEERAR, INC. – Abbott Laboratories Transaction History
NEWMAN DIGNAN & SHEERAR, INC. portfolio value:
$582,000
portfolio value
NEWMAN DIGNAN & SHEERAR, INC. quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -1.59% | -97 shares | -82K | $96.76 | 6.01K |
Q2 2022 | share | 0.00% | 0 shares | -59K | $108.65 | 6.10K | |
Q1 2022 | share | Increase | +4.52% | 264 shares | -100K | $118.36 | 6.10K |
Q4 2021 | share | 0.00% | 0 shares | 133K | $141 | 5.84K | |
Q3 2021 | share | Decrease | -2.50% | -150 shares | -5K | $117.68 | 5.84K |
Q2 2021 | share | 0.00% | 0 shares | -23K | $115.05 | 5.99K | |
Q1 2021 | share | Decrease | -3.46% | -215 shares | -6.08M | $118.49 | 5.99K |
Q4 2020 | share | 0.00% | 0 shares | 6.12M | $107.81 | 6.21K | |
Q3 2020 | share | 0.00% | 0 shares | 45K | $106.81 | 6.21K | |
Q2 2020 | share | Decrease | -4.94% | -323 shares | 37K | $89.39 | 6.21K |
Q1 2020 | share | Increase | +3.35% | 212 shares | 45K | $76.84 | 6.53K |
Q4 2019 | share | Decrease | -1.56% | -100 shares | 12K | $84.23 | 6.32K |
Q3 2019 | share | Decrease | -3.02% | -200 shares | -20K | $80.81 | 6.42K |
Q2 2019 | share | Decrease | -1.85% | -125 shares | 18K | $80.92 | 6.62K |
Q1 2019 | share | Decrease | -1.46% | -100 shares | 44K | $76.6 | 6.74K |
Q4 2018 | share | Decrease | -0.73% | -50 shares | 1K | $68.98 | 6.84K |
Q3 2018 | share | Increase | +2.83% | 190 shares | 85K | $69.69 | 6.89K |
Q2 2018 | share | 0.00% | 0 shares | 17K | $57.68 | 6.70K | |
Q1 2018 | share | 0.00% | 0 shares | 9K | $56.4 | 6.70K | |
Q4 2017 | share | Decrease | -1.31% | -89 shares | 20K | $53.46 | 6.70K |
Q3 2017 | share | Decrease | -5.23% | -375 shares | 14K | $49.74 | 6.79K |
Q2 2017 | share | 0.00% | 0 shares | 31K | $45.07 | 7.17K | |
Q1 2017 | share | 0.00% | 0 shares | 43K | $40.93 | 7.17K | |
Q4 2016 | share | 0.00% | 0 shares | -28K | $35.17 | 7.17K | |
Q3 2016 | share | Decrease | -3.37% | -250 shares | 11K | $38.48 | 7.17K |
Q2 2016 | share | Decrease | -0.67% | -50 shares | -20K | $35.55 | 7.42K |
Q1 2016 | share | Decrease | -5.68% | -450 shares | -44K | $37.6 | 7.47K |